Pfizer
Bookmark
SharePfizer is a company. It is in New York, the United States and its CEO is Albert Bourla. It was founded in 1848 and is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: New York
- state: NY
- country: United States
- employees: 79,000 people
- revenues: 101.3B $
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1848
- CEO: Albert Bourla
- CEO approval: 72 %
- ESG score: Try Pro to see estimate
- environmental score (ESG): Try Pro to see estimate
- social score (ESG): Try Pro to see estimate
- governance score (ESG): Try Pro to see estimate
See more facts
Extract data
Download datasets about Pfizer:
Dataset of stocks from Pfizer:
Pfizer is one of the companies in Pharmaceuticals, companies in Health Care, companies in New York, companies in the United States and 3,456,835 companies in our database.
Talking Points
- Pfizer: One of the world's premier biopharmaceutical companies
- Discover the commonalities and differences between biologics vs. biosimilars — especially when it comes to cost.
- Breakthroughs that change patients' lives. Visit https://t.co/zipcKiopV3 to learn more. https://t.co/FPP9fminSw
- Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that ...
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
- Gene Therapy | Pfizer
- 6101 Quadrangle Drive Suite 200 Chapel Hill, NC 27517, US Get directions Employees at Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. Angelique Camp QA Manager, Pfizer Inc....
- Expanded Access & Compassionate Use | Pfizer
- Patients facing serious illnesses who have exhausted all available treatment options often want to know if and how they can receive early access to investigational drugs that haven’t yet been approved by government regulatory agencies. The information below explains options that may be available to patients in these circumstances.
- Amplyx was founded on a mission to save lives by developing a new class of antifungal medicine that would overcome the severe limitations of today's therapeutic options. We are developing first-in-class products for the treatment of life-threatening infections, with a near-term focus on deadly fungal pathogens in ...
- Pfizer Completes Acquisition of Hospira | Pfizer
- Pfizer Inc. (NYSE:PFE) today announced that it has completed its acquisition of Hospira, Inc.
- Hospira Produtos Hospitalares Ltda is a company based out of Av. Engenheiro Luis Carlos Berrini 901, 1º Andar, Sao Paulo, Sao Paulo, Brazil.
